Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Frydecka

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Acta Haematologica Polonica|January 1, 1994
[Circulating cell differentiation antigens as markers of activity in lymphoproliferative diseases]I Frydecka
Przeglad Lekarski|January 1, 1988
[Cytotoxic NK cells: their role and function in the body. I. Origin of NK cells, their morphological characteristics, location, genetic control and the methods of evaluation of their activity]I Frydecka
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 15, 1983
[Telangiectatic granuloma of the oral cavity in chronic thrombopenia]A Badurowa, I Frydecka
Acta Haematologica Polonica|January 1, 1993
[Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states]G Mazur, I Frydecka
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 29, 1973
[Effect of therapeutic doses of triamcinolone on gastric secretion of acid, pepsin and some protein components]W Bochenek, I Frydecka
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1980
Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemiaI Frydecka, M Becker
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|February 1, 1971
[Role of hypocalcemia in the development of uremic coma]A Szczeklik, I Frydecka
Acta Haematologica Polonica|January 1, 1991
The soluble interleukin-2 receptor: a new humoral marker in hematological malignanciesI Frydecka, K Kuliczkowski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 1, 1972
[Bilateral bundle-branch block in myocardial infarct]A Szczeklik, I Frydecka
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1996
Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patientsI Frydecka, G Mazur
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Acta Haematologica Polonica|January 1, 1994
[Circulating cell differentiation antigens as markers of activity in lymphoproliferative diseases]I Frydecka
Przeglad Lekarski|January 1, 1988
[Cytotoxic NK cells: their role and function in the body. I. Origin of NK cells, their morphological characteristics, location, genetic control and the methods of evaluation of their activity]I Frydecka
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 15, 1983
[Telangiectatic granuloma of the oral cavity in chronic thrombopenia]A Badurowa, I Frydecka
Acta Haematologica Polonica|January 1, 1993
[Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states]G Mazur, I Frydecka
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 29, 1973
[Effect of therapeutic doses of triamcinolone on gastric secretion of acid, pepsin and some protein components]W Bochenek, I Frydecka
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1980
Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemiaI Frydecka, M Becker
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|February 1, 1971
[Role of hypocalcemia in the development of uremic coma]A Szczeklik, I Frydecka
Acta Haematologica Polonica|January 1, 1991
The soluble interleukin-2 receptor: a new humoral marker in hematological malignanciesI Frydecka, K Kuliczkowski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 1, 1972
[Bilateral bundle-branch block in myocardial infarct]A Szczeklik, I Frydecka
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1996
Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patientsI Frydecka, G Mazur
Pageof 9